| RS2058974109 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Colorectal cancer |
| RS2058975287 |
AGXT
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type I |
| RS2058978377 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2058978388 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2058986184 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2058986411 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2058989559 |
AGXT
|
Health Risk |
Likely pathogenic |
— |
| RS2058990168 |
AGXT
|
Health Risk |
Likely pathogenic |
— |
| RS2059009080 |
NEDD4L
|
Health Risk |
Conflicting classifications of pathogenicity |
Periventricular nodular heterotopia 7, Periventricular nodular heterotopia 7 |
| RS2059009305 |
NEDD4L
|
Health Risk |
Conflicting classifications of pathogenicity |
NEDD4L-related disorder, Inborn genetic diseases |
| RS2059018297 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2059020261 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2059021664 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2059021939 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2059037657 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2059045469 |
ALG5
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 7, Polycystic kidney disease 7 |
| RS2059047548 |
EP300
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2059047949 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2059050320 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2059050708 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2059051273 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2059058650 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS2059067761 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS2059069232 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2059069286 |
CACNA1A
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 6, Developmental and epileptic encephalopathy |
| RS2059089321 |
EP300
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2059103511 |
EP300
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, EP300-related disorder |
| RS2059119564 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2059120434 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, RASopathy |
| RS2059121113 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2059122469 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2059125367 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2059127438 |
ERBB2
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS2059129170 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal recessive Alport syndrome |
| RS2059152743 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2059153923 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2059154269 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2059164609 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2059164764 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2059175292 |
TCF12
|
Health Risk |
Pathogenic/Likely pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2059176610 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2059176668 |
EP300
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2059177123 |
EP300
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2059190701 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2059190992 |
CACNA1A
|
Health Risk |
Pathogenic |
Disorder of sexual differentiation, Disorder of sexual differentiation |
| RS2059194330 |
NEDD4L
|
Health Risk |
Pathogenic/Likely pathogenic |
Periventricular nodular heterotopia 7, Intellectual disability |
| RS2059200372 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS2059209950 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS2059210417 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2059211409 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2059213874 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2059215587 |
EP300
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2059219404 |
EP300
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2059220495 |
EP300
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2059220693 |
EP300
|
Health Risk |
Likely pathogenic |
Menke-Hennekam syndrome 2, Menke-Hennekam syndrome 2 |
| RS2059231880 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2059233076 |
NPC1
|
Health Risk |
Pathogenic |
Sphingomyelin/cholesterol lipidosis, Niemann-Pick disease |
| RS2059233326 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2059233403 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2059270260 |
FRA10AC1
|
Health Risk |
Pathogenic |
— |
| RS2059358378 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2059360185 |
COL4A4
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Alport syndrome |
| RS2059384530 |
ABAT
|
Health Risk |
Likely pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS2059397603 |
BPTF
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2059439923 |
DIP2A
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2059495906 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2059501959 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2059557090 |
RTTN
|
Health Risk |
Likely pathogenic |
— |
| RS2059583625 |
LGI1
|
Health Risk |
Likely pathogenic |
Epilepsy, familial temporal lobe |
| RS2059586444 |
LGI1
|
Health Risk |
Likely pathogenic |
Epilepsy, familial temporal lobe |
| RS2059592140 |
SSX1
|
Health Risk |
Pathogenic |
Spermatogenic failure, X-linked |
| RS2059593242 |
LGI1
|
Health Risk |
Likely pathogenic |
Epilepsy, familial temporal lobe |
| RS2059635206 |
GSN
|
Health Risk |
Likely pathogenic |
Finnish type amyloidosis, Finnish type amyloidosis |
| RS2059639706 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2059642653 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2059643357 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2059646164 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2059661877 |
MYLK
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS2059685666 |
EML1
|
Health Risk |
Pathogenic |
— |
| RS2059695805 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2059701389 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2059702093 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2059709974 |
TRPM7
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS2059723813 |
NEDD4L
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia 7, Periventricular nodular heterotopia 7 |
| RS2059726758 |
NEDD4L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2059732940 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS2059732983 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Alport syndrome, Benign familial hematuria |
| RS2059733367 |
COL4A4
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS2059734968 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS2059821994 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2059823776 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2059860543 |
ERBB2
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS2059889716 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS2059899625 |
RTTN
|
Health Risk |
Pathogenic |
— |
| RS2059913524 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2059916812 |
PPFIBP1
|
Health Risk |
Pathogenic |
Microcephaly, Severe intellectual disability |
| RS2059934937 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2059951179 |
LGI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant epilepsy with auditory features, Inborn genetic diseases |
| RS2059955751 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS2059956960 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |